Skip Navigation
Skip to contents

Blood Res.  2016 Jun;51(2):137-138. 10.5045/br.2016.51.2.137.

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab

Affiliations
  • 1Hematology Unit, Sant'Eugenio Hospital, Rome, Italy. pniscola@gmail.com

Abstract

No abstract available.


MeSH Terms

Red-Cell Aplasia, Pure*
Rituximab*
Rituximab
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr